Clinical Trial Update: Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa [Phase 2]

View source ↗

Summary

Phase 2 human challenge trial evaluating next-generation live-attenuated rotavirus vaccines in Africa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Next-generation live-attenuated Rotavirus vaccine (investigational) (Rotavirus vaccine (live-attenuated))

Snippet

Sponsor: Centre for Infectious Disease Research in Zambia | Conditions: Diarrhea, Diarrhea Rotavirus | Phase 2 | Status: COMPLETED